- United States
- /
- Telecom Services and Carriers
- /
- NasdaqGS:SPCX
Space Exploration Technologies (SPCX) Sets New Starship Reflight Timeline After Reuse Milestone
- Space Exploration Technologies (NasdaqGS: SPCX) chief executive Elon Musk flagged a major Starship reusability milestone and a new target timeline for the first upper stage reflight.
- Musk indicated that the company is moving closer to attempting a catch and reuse of the Starship upper stage using the launch tower infrastructure at its Starbase site.
- The update points to a potential shift in how frequently Starship vehicles could be turned around for orbital missions once upper stage reflight is proven.
- Investors are watching for confirmation of test dates and technical details, given the implications for SpaceX launch economics and long term business planning.
Consider using this news as a starting point to explore other stocks tied to the future of space and advanced computing through 56 AI infrastructure stocks.
Space Exploration Technologies operates a satellite-based broadband business that serves customers in the US, Ireland, Canada and other international markets. Any progress on reusing its Starship upper stage feeds directly into how efficiently it can deploy and maintain this global telecom infrastructure.
We've flagged 2 risks for Space Exploration Technologies. See which could impact your investment.
What Starship upper stage reuse could change for the Space Exploration Technologies story
For investors, the Starship reusability milestone mainly speaks to the existing Space Exploration Technologies Narrative around launch economics and capital intensity. If Starship upper stages can be reliably caught and reflown, it would directly connect to the catalyst that highlights heavy spending on Starship and launch infrastructure and the goal of improving unit economics in the Space segment. The key question for you is whether progress on reuse eventually eases the pressure from large capex commitments that currently sit as a risk in the Narrative.
If we take a look at the community Narrative for Space Exploration Technologies, we can see how this news fits into the bigger investment story.
From here, a practical marker to watch is the first successful reflight of a Starship upper stage within the new timeline Musk has outlined, followed by disclosed data points on how many upper stage flights management is targeting per vehicle. Those operational metrics will help you judge whether Starship can realistically support the longer term Connectivity, Space and AI compute plans that Space Exploration Technologies is funding today.
For the full picture including more risks and rewards, check out the complete Space Exploration Technologies analysis.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.
There’s a 60% to 85% probability of the vaccine being approved based on historical drug development data. Could be a lot of scrutiny by the FDA due to the novel platform used.
Market might be getting a little ahead of itself here.
About NasdaqGS:SPCX
Space Exploration Technologies
Provides satellite-based broadband services in the United States, Ireland, Canada, and internationally.
Exceptional growth potential with adequate balance sheet.